Over a span of close to 40 years, Dr. Jeremy Freeman has treated more than 7,000 patients with head and neck cancers and consulted on thousands more of the globe’s most complex cases.
He has pioneered innovative surgical procedures that have become world standards, including techniques for treating recurrent thyroid cancer, and is one of the few international surgeons invited to Israel to treat the most complex surgical cases.
In 2009, Dr. Freeman launched the World Congress on Thyroid Cancer. The first and largest of its kind, it brings together clinical experts to dedicated to the field of thyroid oncology. He also created the Head and Neck Oncologic Surgery Fellowship, one of the world’s largest and considered among top three in North America. Awarded prestigious University of Toronto Colin Woolf Award for Medical Education twice, he has trained and supervised 200+ residents and 70 fellows.
Dr. Freeman has published almost 300 articles, including seminal papers in which he: discovered a critical link between Epstein-Barr virus and nasopharyngeal cancer; pioneered a screening test for use among high-risk populations, enabling prevention and early diagnosis; developed new treatment standards for postoperative thyroid cancer patients, including restricting the use of radioactive iodine, resulting in significant reduction of unnecessary treatment, improving patient quality of life and leading to major health-care savings.
Through two landmark papers, in 1987 and 1990, set the guidelines and standards for diagnosis of metastatic neck nodes by CT and MRI, which remain in use today.
When Dr. Freeman became frustrated with the long wait lists facing his cancer patients, he learned ultrasound. Once he became proficient in that, he taught courses in ultrasonography to fellow clinicians. Because of him, many cancer patients across the province have one-stop access to the treatment and imaging they need.
Dr. Freeman has personally contributed over $1 million towards furthering research and developing the next generation of experts. Through the Harry Barberian Annual Memorial Dinner, he raises $100,000 each year to support young researchers. Using personal funds, he established Chapnik, Freeman, Friedberg Award, one of the largest private awards given by faculty in Canada to support young researchers. Along with Albert Latner, helped establish the Temmy Latner Palliative Program at Sinai Health.
He has pioneered innovative surgical procedures that have become world standards, including techniques for treating recurrent thyroid cancer, and is one of the few international surgeons invited to Israel to treat the most complex surgical cases.
In 2009, Dr. Freeman launched the World Congress on Thyroid Cancer. The first and largest of its kind, it brings together clinical experts to dedicated to the field of thyroid oncology. He also created the Head and Neck Oncologic Surgery Fellowship, one of the world’s largest and considered among top three in North America. Awarded prestigious University of Toronto Colin Woolf Award for Medical Education twice, he has trained and supervised 200+ residents and 70 fellows.
Dr. Freeman has published almost 300 articles, including seminal papers in which he: discovered a critical link between Epstein-Barr virus and nasopharyngeal cancer; pioneered a screening test for use among high-risk populations, enabling prevention and early diagnosis; developed new treatment standards for postoperative thyroid cancer patients, including restricting the use of radioactive iodine, resulting in significant reduction of unnecessary treatment, improving patient quality of life and leading to major health-care savings.
Through two landmark papers, in 1987 and 1990, set the guidelines and standards for diagnosis of metastatic neck nodes by CT and MRI, which remain in use today.
When Dr. Freeman became frustrated with the long wait lists facing his cancer patients, he learned ultrasound. Once he became proficient in that, he taught courses in ultrasonography to fellow clinicians. Because of him, many cancer patients across the province have one-stop access to the treatment and imaging they need.
Dr. Freeman has personally contributed over $1 million towards furthering research and developing the next generation of experts. Through the Harry Barberian Annual Memorial Dinner, he raises $100,000 each year to support young researchers. Using personal funds, he established Chapnik, Freeman, Friedberg Award, one of the largest private awards given by faculty in Canada to support young researchers. Along with Albert Latner, helped establish the Temmy Latner Palliative Program at Sinai Health.
He has pioneered innovative surgical procedures that have become world standards, including techniques for treating recurrent thyroid cancer, and is one of the few international surgeons invited to Israel to treat the most complex surgical cases.
In 2009, Dr. Freeman launched the World Congress on Thyroid Cancer. The first and largest of its kind, it brings together clinical experts to dedicated to the field of thyroid oncology. He also created the Head and Neck Oncologic Surgery Fellowship, one of the world’s largest and considered among top three in North America. Awarded prestigious University of Toronto Colin Woolf Award for Medical Education twice, he has trained and supervised 200+ residents and 70 fellows.
Dr. Freeman has published almost 300 articles, including seminal papers in which he: discovered a critical link between Epstein-Barr virus and nasopharyngeal cancer; pioneered a screening test for use among high-risk populations, enabling prevention and early diagnosis; developed new treatment standards for postoperative thyroid cancer patients, including restricting the use of radioactive iodine, resulting in significant reduction of unnecessary treatment, improving patient quality of life and leading to major health-care savings.
Through two landmark papers, in 1987 and 1990, set the guidelines and standards for diagnosis of metastatic neck nodes by CT and MRI, which remain in use today.
When Dr. Freeman became frustrated with the long wait lists facing his cancer patients, he learned ultrasound. Once he became proficient in that, he taught courses in ultrasonography to fellow clinicians. Because of him, many cancer patients across the province have one-stop access to the treatment and imaging they need.
Dr. Freeman has personally contributed over $1 million towards furthering research and developing the next generation of experts. Through the Harry Barberian Annual Memorial Dinner, he raises $100,000 each year to support young researchers. Using personal funds, he established Chapnik, Freeman, Friedberg Award, one of the largest private awards given by faculty in Canada to support young researchers. Along with Albert Latner, helped establish the Temmy Latner Palliative Program at Sinai Health.
Dr. Jeremy Freeman is an icon in the world of head & neck surgical oncology. He has cured innumerable people of cancer and taught surgeons from around the world.
Dr. Matthew Magarey, ENT surgeon, Australia
About Mount Sinai 100 Chairs
In 2023, Mount Sinai Hospital will mark its 100th anniversary. To honour the physicians and scientists who have made breakthrough discoveries and whose achievements have elevated Sinai Health’s reputation for world-class care, we are pleased to introduce our Mount Sinai 100 Chairs. These legacy chairs carry the names of Sinai Health’s most eminent trailblazers and will help recruit and fund the work of a new generation of clinicians and scientists, securing the next century of caring at Sinai Health. We invite you to help us imagine the next 100 years.
About Mount Sinai 100 Chairs
In 2023, Mount Sinai Hospital will mark its 100th anniversary. To honour the physicians and scientists who have made breakthrough discoveries and whose achievements have elevated Sinai Health’s reputation for world-class care, we are pleased to introduce our Mount Sinai 100 Chairs. These legacy chairs carry the names of Sinai Health’s most eminent trailblazers and will help recruit and fund the work of a new generation of clinicians and scientists, securing the next century of caring at Sinai Health. We invite you to help us imagine the next 100 years.
About Mount Sinai 100 Chairs
In 2023, Mount Sinai Hospital will mark its 100th anniversary. To honour the physicians and scientists who have made breakthrough discoveries and whose achievements have elevated Sinai Health’s reputation for world-class care, we are pleased to introduce our Mount Sinai 100 Chairs. These legacy chairs carry the names of Sinai Health’s most eminent trailblazers and will help recruit and fund the work of a new generation of clinicians and scientists, securing the next century of caring at Sinai Health. We invite you to help us imagine the next 100 years.
